Published in Women's Health Weekly, February 19th, 2000
H. H. Nelson and colleagues at Harvard University examined the occurrence of K-ras mutation NSCLC in order to define patient characteristics associated with K-ras mutation and to find whether K-ras mutation might be a marker of patient prognosis ("Implications and prognostic value of K-ras mutation for early-stage lung cancer in women," Journal of the National Cancer Institute, 1999;91(23):2032-2038).
Nelson et al. examined consecutive, newly diagnosed patients with lung cancer who had been treated with potentially curative...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly